In the first study to directly compare dolutegravir to other antiretroviral regimens listed as 'Preferred' in U.S. perinatal guidelines, pregnant people who took dolutegravir-based regimens had a high probability of being virally suppressed at delivery.
from Top Health News -- ScienceDaily https://ift.tt/fYa9nrb
Health, Fitness,Dite plan, health tips,athletic club,crunch fitness,fitness studio,lose weight,fitness world,mens health,aerobic,personal trainer,lifetime fitness,nutrition,workout,fitness first,weight loss,how to lose weight,exercise,24 hour fitness,
Labels
Technology
New Post
[recent][newsticker]
MKRdezign
Powered by Blogger.
Post a Comment